Posted on October 27,2013 in Illinois Defective Medical Products Lawyer

Metallosis is a side effect experienced by some individuals who have metal on metal hip replacements. It results from metal corrosion and release of wear debris from the device into the body of the patient. For the patients who underwent surgery to receive metal hip replacements, what they hoped would make their lives easier could actually end in pain, suffering, and a defective medical device lawsuit.

Hip resurfacing techniques were developed in the 1970's with the goal of limiting bone resection, risk of dislocation, and wear, but the method that was used had a high failure rate, bringing researchers back to the drawing table. Since then, hip resurfacing reemerged in the 1990's with what seemed like positive results. After patients began going through the hip replacement process, however, there were multiple impacts on patients who were given defective hip replacements.

Continue Reading ››

 Posted on October 23,2013 in Defective Medical Devices

Boston Scientific, a medical device manufacturer, and its subsidiary company, Guidant, has been ordered by the US Justice Department to pay out over $30 million to settle charges that the company knowingly sold defective heart devices that were used in Medicare recipients.

According to an article by the Mississippi Sun Herald, the US Justice department claimed that the company knew there was a problem and was taking corrective action to fix it. However, at the same time, the company continued to sell selective products. Additionally, while the company was under investigation for faulty device manufacturing, it took steps to cover up the problem from patients.

While this lawsuit was a criminal matter, it may become important in future civil lawsuits as well. This establishes that Boston Scientific may have been intentionally placing defective medical devices into the marketplace.

Defective Medical Devices: A Violation of a Duty

Medical device manufacturers have a duty to ensure that the products they send to market are effective and safe. When a manufacturer fails to take these precautions, patients who use their devices can suffer devastating injuries or even death. In these cases, the law provides for a mechanism to hold the manufacturer of the faulty device accountable; this is called product liability.

Continue Reading ››

 Posted on October 20,2013 in Defective Medical Devices

A new study published in the Journal of Patient Safety has concluded that the number of patients who die from medical mistakes in hospitals is significantly higher than past studies have revealed.

In 1999, a report titled “To Err is Human,” which was published by the Institute of Medicine, put that number at 98,000. At the time the report was published, the medical community balked that number but in time accepted it as factual.

Eleven years later, the Office of Inspector General for Health and Human Services released results from a study of how many Medicare patients die each year from medical mistakes in hospitals. Their conclusion was 180,000. Remember – that is the total of only Medicare patients.

This new study puts the total number of patients who die due to preventable medical errors at a whopping 210,000 to 440,000 per year – the third leading cause of death in this country, following heart disease and cancer. According to ProPubilca, these figures were compiled by John T. James, who runs Patient Safety in America. James is also a toxicologist at NASA. He has first-hand experience with this subject, having lost his 19 year-old son from hospital negligence.

Continue Reading ››

 Posted on October 19,2013 in Defective Medical Devices

It was recently reported in Insurance Journal that a $15 million radiation treatment lawsuit settlement was finalized. The lawsuit was filed by the family of Zacarias Chichioco, Jr., who died in 2011, against Varian Medical Systems Inc. and physicians affiliated with the Pacific Cancer Institute in Wailuku, Hawaii.

According to the article, the victim was diagnosed with lung cancer in February 2008. He was being treated by Dr. Daryl Makishi, a doctor at the Pacific Institute. Dr. Makishi developed a treatment plan of radiation treatments for his patient. Chichioco received 35 radiation treatments delivered through a linear accelerator which was developed by Varian Medical Systems.

Very quickly after beginning these treatments, Chichioco began hallucinating and had pain when swallowing. He also suffered hearing loss and the left side of his face became paralyzed. He was operated on for skin grafts in the hopes to alleviate these symptoms, but nothing worked.

Continue Reading ››

 Posted on October 15,2013 in Defective Medical Devices

The business of hip and knee implants is growing. It's not just baby boomers who need these implants, but the under 65 market is expanding as well. Estimates are that by 2030 when 4 million replacements will be put in, half of all patients will be under 65. Since people are getting replacements at a younger age, they will have these implants for a longer time.

Consumers Union, the advocacy side of Consumer Reports, has stated that since these people will have the implants longer, then they should be backed by a warranty. They feel that patients should know how long these replacements should last. It would also be good for patients to have a clear recourse if their devices fail. Now this advocacy group has asked manufacturers to provide warranties for their products which would have them replaced at no cost within the warranty period of 20 years.

Continue Reading ››

 Posted on October 08,2013 in Drugs

Doctors spend years studying medicine before they are allowed to make care decisions. Even once they receive their doctoral degrees, they work underneath doctors with tenure and on the job experience. Yet the fear of lawsuits makes most doctors practice defensive medicine. That means that instead of focusing on helping a patient, these doctors are practice medicine to avoid legal action.

Defensive medicine is when doctors second guess their initial diagnosis. Instead of treating the condition that the symptoms point to, the doctor will order additional tests, procedures and other diagnosis tools to rule out other possible options. Defensive medicine can also mean that doctors avoid certain patients or procedures that are high-risk.

It might not seem to be commonplace but it is. Jackson Healthcare, a large healthcare staffing agency, said that 75 percent of doctors practice defensive medicine. Even though it would seem that over testing is a good practice, especially since the high stakes associated with healthcare, but the opposite might be true.

Continue Reading ››

 Posted on October 03,2013 in Defective Medical Devices

With the government shutdown looming over Washington and numerous federal locations across the country, the Consumer Product Safety Commission (CPSC) announced that their inspectors would be told to stay home as well. The Food and Drug Administration, which holds the responsibility for inspecting the food eaten all around the nation, suspended their regular inspections and monitoring activities for imported food and drugs. Illinois residents may receive injuries as the result of recalled or dangerous products, which may lead to an increasing number of personal injury lawsuits.

The Center for Disease Control and Prevention officially furloughed nearly 70% of their existing staff, with the remaining personnel expressing concern about their ability to respond to any disease or food outbreaks. Since the length of the shutdown is currently unknown, there could be dire consequences from the shutdown that won't even be known for weeks or months after it's resolved. With the CPSC for the most part offline, the lack of reviewing and monitoring activities will lead to a pileup of work to be completed when the government returns to work. In the meantime, consumers across America could be interacting with dangerous products.

Continue Reading ››

 Posted on September 26,2013 in FDA

Our law firm uses this forum to help keep readers informed of U.S. Food and Drug Administration (FDA) recalls. When the FDA does issue a recall, the also 'classify' it – Class I, Class II or Class III, depending on the hazard involved.

But what exactly are the differences between those three FDA recall classifications?

According to the FDA's website, when the agency determines that a product is either defective or potentially harmful, either directly from the manufacturer of the product or by doctor/patient complaints, recalling the product is the most effective way to protect patients.

The majority of recalls are voluntary. Either a company discovers a defective or problem and recalls a product on its own or will announce a recall after the FDA raises concerns. Only in rare cases will FDA request a recall.

A Class I recall is the most serious and is issued when a dangerous or defective product could predictably cause serious injury or death.

Continue Reading ››

 Posted on September 22,2013 in Illinois Defective Medical Products Lawyer

A nasty fungal meningitis outbreak in Tennessee has left several families and patients reeling with new injuries sustained after a tainted steroid shot was administered in several facilities across the state, according to The Tennessean. One of the recent lawsuits to be filed due to this incident was filed on behalf of Major Adam Ziegler, 33. Major Ziegler is a veteran of wars in both Iraq and Afghanistan. His 49-page complaint, according to The Tennessean, states that the continued nerve damage in his feet and legs, incurred by the tainted steroid, has “negatively impacted his military career.”

Yet Major Ziegler is luckier than some of his counterparts. One lawsuit was filed “for the family of retired Nashville school librarian Earline Williams, one of the early victims to die in the nationwide fungal meningitis outbreak.” The outbreak first rocked medical facilities across the country in October of last year, and according to The Tennessean, the recent “flurry of lawsuits comes as a one-year deadline is approaching to assert claims under Tennessee's health care and product liability laws.”

Continue Reading ››

 Posted on September 18,2013 in FDA

Despite the rising number of lawsuits being brought against pharmaceutical giants, the Food and Drug Administration (FDA) recently announced that it will continue to increase the number of drugs it fast-tracks for approval, according to NaturalNews.com. The approval-acceleration program is known as “Fast Track, Accelerated Approval and Priority Review,” according to NaturalNews, “which is really just a fraudulent shortcut method for drug companies to rush potentially-deadly new drugs to market without appropriate regulatory review.” Such drugs that the FDA plans to put into this program, according to NaturalNews, include obesity treatments, antibiotics, and cancer treatments. Oftentimes these drugs will get an FDA seal of approval without having undergone extensive clinical trials. They'd also have “smaller sample sizes and entail shorter duration periods” of trials, according to NaturalNews.

Continue Reading ››